GENTILE, Vittorio
 Distribuzione geografica
Continente #
EU - Europa 6.563
NA - Nord America 3.113
AS - Asia 2.048
SA - Sud America 317
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 18
OC - Oceania 1
Totale 12.193
Nazione #
RU - Federazione Russa 3.368
US - Stati Uniti d'America 3.074
FI - Finlandia 790
SG - Singapore 780
IT - Italia 672
IE - Irlanda 662
CN - Cina 372
UA - Ucraina 361
HK - Hong Kong 316
BR - Brasile 273
GB - Regno Unito 273
VN - Vietnam 215
DE - Germania 173
KR - Corea 144
SE - Svezia 80
IN - India 62
TR - Turchia 62
GR - Grecia 55
FR - Francia 51
JP - Giappone 24
BD - Bangladesh 20
AR - Argentina 16
BE - Belgio 14
CA - Canada 13
MX - Messico 13
NL - Olanda 13
AT - Austria 11
ES - Italia 10
ID - Indonesia 10
PK - Pakistan 10
CH - Svizzera 6
EC - Ecuador 6
EU - Europa 6
HU - Ungheria 6
PE - Perù 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
CO - Colombia 4
DO - Repubblica Dominicana 4
HN - Honduras 4
IR - Iran 4
KE - Kenya 4
MA - Marocco 4
PY - Paraguay 4
RS - Serbia 4
CL - Cile 3
PL - Polonia 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
CR - Costa Rica 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
Totale 12.066
Città #
Moscow 1.183
Helsinki 697
Dublin 661
Jacksonville 542
Santa Clara 394
Chandler 325
Hong Kong 316
Singapore 296
Caserta 201
San Jose 196
Ashburn 178
Seoul 138
Naples 110
Princeton 96
Medford 82
Ann Arbor 77
Beijing 69
Ho Chi Minh City 69
Boardman 68
Hanoi 58
Dallas 56
Memphis 50
San Mateo 49
Roxbury 41
Wilmington 39
Woodbridge 38
Hefei 37
Bengaluru 35
New York 31
Cambridge 30
Los Angeles 28
Aversa 26
Milan 25
Napoli 25
São Paulo 25
The Dalles 24
Des Moines 21
Dong Ket 18
Munich 15
Orem 15
Atlanta 14
Rome 14
Brussels 13
Rio de Janeiro 13
Bremen 10
Chicago 10
Belo Horizonte 9
Da Nang 9
Haiphong 9
Mountain View 9
Nuremberg 9
Dover 8
Düsseldorf 8
Nanjing 8
Norwalk 8
Auburn Hills 7
Bologna 7
Chennai 7
Guangzhou 7
Mexico City 7
San Francisco 7
Tokyo 7
Brooklyn 6
Denver 6
Florence 6
Frankfurt am Main 6
London 6
Louisville 6
Redwood City 6
Toronto 6
Amsterdam 5
Brno 5
Brusciano 5
Caerano di San Marco 5
Fortaleza 5
Houston 5
Stockholm 5
Turku 5
Vienna 5
Baghdad 4
Boston 4
Capaccio 4
Council Bluffs 4
Fermo 4
Istanbul 4
Jinan 4
Miami 4
Milwaukee 4
Molfetta 4
Montreal 4
Mumbai 4
Nairobi 4
Newark 4
Ormskirk 4
Paris 4
Quarrata 4
Ribeirão das Neves 4
San Giorgio Del Sannio 4
Sant'Antonio Abate 4
Shijiazhuang 4
Totale 6.761
Nome #
Tissue transglutaminase expression affects hypusine metabolism in BALB/c 3T3 cells 784
Un modello di malattia da poliglutammine: clinica e diagnosi della Corea di Huntington 255
Possible Roles of the Transglutaminases in the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases 227
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 211
Abnormal accumulation of tTGase products in muscle and erythrocytes of chorea-acanthocytosis patients 203
A novel G-protein active on signal transduction 187
Possible Roles of the Transglutaminases in the Molecular Mechanisms Responsible for Human Neurological Diseases 171
Amyloid-β-Induced Transglutaminase 2 Expression and Activities Are Modulated by 2-Pentadecyl-2-Oxazoline in Mouse and Human Microglial Cell Lines 170
Meet Our Editorial Board Member 170
PHYSIOPATHOLOGICAL ROLES OF THE HUMAN TRANSGLUTAMINASE 2, THE “TISSUE” TRANSGLUTAMINASE (TG2), AND ITS POSSIBLE INVOLVEMENT IN NEURODEGENERATIVE DISEASES 161
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 161
Immune cell infiltration and inflammatory landscape in primary brain tumours 160
B-lipotropin 61-76 and 61-91 fragments act as transglutaminase substrates in vitro 159
A Biochemical Mechanism for a Transglutaminase-Mediated Cell Death in CAG Triplet Diseases: Tissue Tranglutaminase-Catalyzed Formation of High Molecular Weight Aggregates With Extended Polyglutamine Peptides and Glyceraldehyde 3-Phospate Dehydrogenase 158
Cell-biomaterial interactions: role of transglutaminase enzyme 151
ESPRESSIONE DELLA TRANSGLUTAMINASI ENDOTELIALE IN TESSUTO DI PROSTATA NORMALE E CARCINOMATOSA E DELL’ATTIVITA’ TRANSGLUTAMINASICA IN CELLULE EPITELIALI DI PROSTATA NORMALE 144
Neuronutraceuticals Modulate Lipopolysaccharide- or Amyloid-β 1-42 Peptide-Induced Transglutaminase 2 Overexpression as a Marker of Neuroinflammation in Mouse Microglial Cells 143
Implication of transglutaminase in mitogen-induced human lymphocyte blast transformation 141
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 140
Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells 138
A role for an "heavy" G-protein on the modulation of the adenylate cyclase activity 136
Biochemical mechanisms for a possible involvement of the transglutaminase activity in the pathogenesis of the polyglutamine diseases 135
Curcumin (Diferulolylmethane) Reduces Transglutaminase 2 Overexpression Induced by Retinoic Acid in Human Nervous Cell Lines 134
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 133
Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides 131
Use of Transglutaminase 2 mRNA expression in peripheral blood mononuclear cells in patients with Radiologically Isolated Syndrome as a neuroinflammation biomarker: A preliminary study. 129
Possible involvement of transglutaminase-catalyzed reactions in the physiopathology of neurodegenerative diseases 128
Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases 124
Defective stabilization of apoptotic cells by “tissue transglutaminase” cross-linking of proteins in MRL lpr/lpr autoimmune mice 123
Cerebral polyamine metabolism: inhibition of spermidine biosynthesis by dicyclohexylamine 123
Are the methionine sulfoximine-induced seizures specifically related to the increase of spermine production? 123
REGULATION OF TISSUE TRANSGLUTAMINASE AND APOPTOSIS IN HUMAN PROSTATE EPITHELIAL CELLS BY RETINOIC ACID. 123
Cereal dietary proteins with sites for cross-linking by transglutaminase 119
Possible role of the Transglutaminases in the pathogenesis of Alzheimer's disease and other Neurodegenerative diseases 119
Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases 119
Transglutaminase inhibition: possible therapeutic mechanisms to protect cells from death in neurological disorders 117
Transglutaminase-Catalyzed Reactions Responsible for the Pathogenesis of Celiac Disease and Neurodegenerative Diseases: From Basic Biochemistry to Clinic 116
Identification of a FXIIIA variant in human neuroblastoma cell lines. 116
Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases 115
Possible roles of transglutaminase-catalyzed reactions in the pathogenesis of human neurodegenerative diseases 115
Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability 113
What is the purpose of launching the Translational Medicine Reports journal? 113
Functional implications of human tissue transglutaminase in the modulation of signal transduction via G-proteins 112
Possible roles of the transglutaminase-catalyzed reactions in the pathogenesis of human neurodegenerative diseases 112
Transglutaminase inhibition: A therapy to protect cells from death in neurodegeneration? 112
Identification and characterisation of brain transglutaminases and their possible involvement in the pathogenesis of polyglutamine diseases 110
Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases? 109
Studio sull’espressione genica delle transglutaminasi e sul loro possibile ruolo nella patogenesi di malattie da poliglutammine 108
Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases 108
Pathophysiological Roles of Transglutaminase - Catalyzed Reactions in the Pathogenesis of Human Diseases 108
Isolation and characterization of the human tissue transglutaminase gene promoter 106
tTGase/G alpha h protein expression inhibits adenylate cyclase activity in Balb-C 3T3 fibroblasts membranes 105
Transglutaminase-mediated modifications of the rat sperm surface in vitro 105
Possible roles of transglutaminases in molecular mechanisms responsible for human neurodegenerative diseases. 105
Purification and partial characterization of transglutaminase secreted from the rat anterior prostate 104
Role of the Transglutaminase Enzymes in the Nervous System and their possible involvement in Neurodegenerative Diseases 103
Tissue transglutaminase (tTGase) a key enzyme in the pathogenesis of Huntington Corea and Neuroacanthocytosis 103
Possible role of the transglutaminase activity in molecular mechanisms responsible for human neurodegenerative diseases 103
Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases 101
Transglutaminases: a possible role in (CAG)n/Qn-expansion diseases and selective vulnerability? 101
Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion 100
Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases 100
Human tissue transglutaminase gene clone as device for detecting celiac disease 100
Possible physiopathological roles of the transglutaminase activity in the etiopathogenesis of human neurodegenerative diseases 99
Retinoid-regulated expression of transglutaminases: links to the biochemistry of cell death 99
Transglutaminases - possible drug targets in human diseases 98
Role of transglutaminase in the maturation of mammalian spermatozoon 96
Transglutaminases as Possible Therapeutic Targets in Neurodegenerative Diseases 96
Striking homology between transglutaminase secreted by the rat coagulating gland and the cDNA-derived amino acid sequence of DP1, a protein occurring in both anterior and dorsal rat prostate 95
Transglutaminase inhibition: possible therapeutic mechanisms to protect cells from death in neurological disorders. 95
The human tissue transglutaminase gene maps on chromosome 20q12 by in situ fluorescence hybridization 94
Transglutaminase activity in rat jejunal mucosa: possible role of the enzyme in the pathogenesis of gluten sensitive enteropathy 94
Physiopathological roles of human transglutaminase 2 94
Possible pathophysiological roles of transglutaminase - catalyzed reactions in the pathogenesis of human neurodegenerative diseases 92
Suppression of rat epididymal sperm antigenicity in vitro by transglutaminase and one of the major protein secreted from the rat seminal vesicle epithelium (SV-IV) 91
Transglutaminase Activity as a Possible Molecular Mechanism in the Etiopathogenesis of Neurodegenerative Diseases 91
L' esperienza del neurologo: la Corea di Huntington 90
Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells 90
Factors modulating immunocompatibility of spermatozoa: role of transglutaminase and SV-IV, one of the major protein secreted from the rat seminal vesicle epithelium 90
Hyperckemia in the neuroacanthocytosis: possible tissutal transglutaminase abnormality in skeletal muscle 90
Transglutaminase-catalyzed post-translational modifications of proteins in the Nervous System and their possible involvement in Neurodegenerative Diseases 88
Occurrence of spermine binding sites in synaptosomal membranes 88
Immunologic properties of rat coagulating gland transglutaminase 87
Transglutaminase-catalyzed modifications of SV-IV, a major protein secreted from the rat seminal vesicle epithelium 87
Tissue transglutaminase expression in Balb-c 3T3 fibroblasts affects hypusine metabolism 87
Possible Role of the Transglutaminases in the Pathogenesis of Neurodegenerative Diseases 87
Possible role of the transglutaminase-catalyzed reactions in the pathogenesis of neurodegenerative diseases 86
Tissue transglutaminase expression in quail epiphyseal chondrocytes 85
Role of Transglutaminase-Catalyzed Reactions in the Post-Translational Modifications of Proteins Responsible for Immunological Disorders 82
Physio-pathological roles of the transglutaminase-catalyzed reactions 82
Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: celiac disease 82
Studies on human semen transglutaminase 80
Spermine binding to subsynaptosomal fractions of rat brain cortex 79
Tissue transglutaminase and coeliac disease pathogenesis: potential molecular mechanisms for other human diseases 79
The importance of the GTP-binding protein tissue transglutaminase in the regulation of cell cycle progression 79
Transglutaminase Inhibition as a Possible Therapeutic Mechanism to Protect Cells from Death in Neurological Disorders 79
Localization of the human prostate transglutaminase (type IV) gene (TGM4) to chromosome 3p21.33-p22 by fluorescence in situ hybridization 78
Polyamines and methionine sulfoximine-induced seizures 78
Transglutaminase covalently incorporates amines into human immunodeficiency virus envelope glycoprotein gp120 in vitro 77
Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth 76
Totale 12.193
Categoria #
all - tutte 39.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.948


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022517 0 16 2 11 198 6 26 9 28 10 52 159
2022/20231.274 125 20 26 138 95 102 1 79 623 8 24 33
2023/2024533 36 18 29 51 181 25 3 19 8 9 41 113
2024/20251.393 8 18 22 36 220 202 136 116 140 336 102 57
2025/20266.161 177 265 269 296 439 3.149 325 109 853 76 157 46
2026/2027129 51 78 0 0 0 0 0 0 0 0 0 0
Totale 12.193